 After Eli Lilly achieved the milestone approval of the weight loss pill Foundayo, Novo Nordisk launched a full-court press to defend oral Wegovy, which has been enjoying a record-breaking launch since January.
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. |
